pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-449b |
Genomic Coordinates | chr5: 55170646 - 55170742 |
Description | Homo sapiens miR-449b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-449b-5p | ||||||||||||||||||
Sequence | 16| AGGCAGUGUAUUGUUAGCUGGC |37 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Microarray | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MAZ | ||||||||||||||||||||
Synonyms | PUR1, Pur-1, SAF-1, SAF-2, SAF-3, ZF87, ZNF801, Zif87 | ||||||||||||||||||||
Description | MYC associated zinc finger protein | ||||||||||||||||||||
Transcript | NM_001042539 | ||||||||||||||||||||
Other Transcripts | NM_002383 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MAZ | |||||||||||||||||||||
3'UTR of MAZ (miRNA target sites are highlighted) |
>MAZ|NM_001042539|3'UTR 1 GGGGGACCCCCGCACCCACCAGGTACTGGTGAGGTTTGTCCAATGGCGGCGGCAGCGGCAGCGGCGGCAGCGGCAGCAGC 81 GGCAGCAGTAGCAGCCCCTCCCACAGCTGTGGGCTCCCTCTCGGGGGCGGAGGGGGTGCCTGTGAGCTCTCAGCCACTTC 161 CCTCCCAACCCTGGTGAGCTCCAAGTTGGTTGCGGGGGAGAGGGGAGAATGGAGTAGAGTCCCTTGGTACAAGCTCCTCT 241 CCCCCCTCTTTTCCCACCAACTCCTATTTCCCTACCAACCAAGGAGCCTCCAGAAGGAAAGGAGGAAGAAATGTTTTCTT 321 AGGGGAATTCGCTAGGTTTTAACGATTTGTTTCTCCTGCTCCTCTTCTATCAGACCTGACCCCACACAAACCTGTCCCCT 401 CGGTTGTGTTGAAGTCCCCTGGACAGTGGGCAGGGGTGGCAGAGGACACGAGCAGCCACTGCCCGTACCCCCTCTCCTCT 481 CTGTAAGCCCATGCCCTGTCTTCCCAGGGACTTGTGAGCCTCTTCCCTCGACGGTCCTCTTCTCTCCTTCCAGTCCTCTC 561 CCCCTGCTGTCTGCAGCCCCTCCCCGGGGAGTTGGTGCTTTCTTTTCCTTTTTTTTTTTTTTCCAGGGGGAGGGAGGAGA 641 GGAAGGAGGGGGATCAGAGCTGTCCCAAAGAGGGAAAGCGGTGAGGTTTGAGGAGGGGCAGAAGCAGGGCCGGCAAAGGT 721 TGTACCTTCATAAGGTGGTATGGGGGGTTGGGGTCAGGCCCTGAACATCGTCCTACTTGAGAATCTGTCAGGGGAAAAAG 801 TCAAGGGGAGCAGGAGGAAGAGCCAGGAGGGCCAGAGGCAGAGAAGAGATGGAGTCTTAGGGGCCAGGGTGAGCGAGGGG 881 TCCAGGGCCTAGAGGTGCTTCCTGGGGGCGGGGGAATGCAGCCAGTGTCCCCCTCCCCTCTTCCACCCCAGCTCCAGCCC 961 TGGTCTTGTCTTTTCATCCCTCTTCCCCACGACAGAAGAAGTTGTGGCCCTGGCCATGTCATCGTGTTCCTGTGTCCCCT 1041 GCATGTACCCCACCCTCCACCCCTTCCTTTTGCGCGGACCCCATTACAATAAATTTTAAATAAAATCCTGTTTCTGGCTC 1121 TGGATTGAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000219782.6 | 3UTR | CCACUGCCCGUACCCCCUCUCCUCUCUGUAAGCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
109 hsa-miR-449b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT006349 | SIRT1 | sirtuin 1 | 2 | 1 | ||||||||
MIRT006350 | CCNE2 | cyclin E2 | 4 | 3 | ||||||||
MIRT006351 | MET | MET proto-oncogene, receptor tyrosine kinase | 2 | 1 | ||||||||
MIRT006352 | GMNN | geminin, DNA replication inhibitor | 2 | 1 | ||||||||
MIRT006353 | HDAC1 | histone deacetylase 1 | 2 | 1 | ||||||||
MIRT016137 | CDK4 | cyclin dependent kinase 4 | 1 | 1 | ||||||||
MIRT016138 | CDC25A | cell division cycle 25A | 2 | 1 | ||||||||
MIRT016139 | CDK6 | cyclin dependent kinase 6 | 4 | 3 | ||||||||
MIRT057740 | ZDHHC16 | zinc finger DHHC-type containing 16 | 2 | 2 | ||||||||
MIRT078636 | FAM104A | family with sequence similarity 104 member A | 2 | 2 | ||||||||
MIRT100407 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 2 | 2 | ||||||||
MIRT115552 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT130146 | TXNIP | thioredoxin interacting protein | 2 | 4 | ||||||||
MIRT142254 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT143724 | CCL22 | C-C motif chemokine ligand 22 | 2 | 2 | ||||||||
MIRT168101 | E2F3 | E2F transcription factor 3 | 2 | 2 | ||||||||
MIRT169809 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 4 | ||||||||
MIRT183694 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT198922 | SMAD4 | SMAD family member 4 | 2 | 2 | ||||||||
MIRT202950 | TSN | translin | 2 | 4 | ||||||||
MIRT221565 | CBX3 | chromobox 3 | 2 | 2 | ||||||||
MIRT253418 | EVI5L | ecotropic viral integration site 5 like | 2 | 2 | ||||||||
MIRT294759 | ZNF551 | zinc finger protein 551 | 2 | 4 | ||||||||
MIRT307053 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT331273 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 6 | ||||||||
MIRT372293 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT374317 | MBD6 | methyl-CpG binding domain protein 6 | 2 | 2 | ||||||||
MIRT445817 | DNAAF3 | dynein axonemal assembly factor 3 | 2 | 2 | ||||||||
MIRT447158 | MFSD8 | major facilitator superfamily domain containing 8 | 2 | 2 | ||||||||
MIRT447823 | CTIF | cap binding complex dependent translation initiation factor | 2 | 2 | ||||||||
MIRT448798 | GMFB | glia maturation factor beta | 2 | 2 | ||||||||
MIRT451580 | HIRIP3 | HIRA interacting protein 3 | 2 | 2 | ||||||||
MIRT452679 | GPR156 | G protein-coupled receptor 156 | 2 | 2 | ||||||||
MIRT453158 | CNOT4 | CCR4-NOT transcription complex subunit 4 | 2 | 6 | ||||||||
MIRT453634 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT455384 | PLA2G2D | phospholipase A2 group IID | 2 | 2 | ||||||||
MIRT456958 | SPAM1 | sperm adhesion molecule 1 | 2 | 2 | ||||||||
MIRT462739 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT464321 | UST | uronyl 2-sulfotransferase | 2 | 2 | ||||||||
MIRT465641 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | 2 | 10 | ||||||||
MIRT466748 | SYNGR2 | synaptogyrin 2 | 2 | 2 | ||||||||
MIRT468345 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT469324 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | 2 | 2 | ||||||||
MIRT474361 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT475316 | IFNLR1 | interferon lambda receptor 1 | 2 | 2 | ||||||||
MIRT477759 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT477824 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | 2 | 2 | ||||||||
MIRT478265 | DDX19B | DEAD-box helicase 19B | 2 | 2 | ||||||||
MIRT481042 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 2 | ||||||||
MIRT481289 | ATXN1L | ataxin 1 like | 2 | 2 | ||||||||
MIRT482730 | COPZ1 | coatomer protein complex subunit zeta 1 | 2 | 2 | ||||||||
MIRT488780 | CYTH3 | cytohesin 3 | 2 | 2 | ||||||||
MIRT489578 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT489659 | SHMT1 | serine hydroxymethyltransferase 1 | 2 | 4 | ||||||||
MIRT490527 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT492949 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT493154 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT493845 | FOXN3 | forkhead box N3 | 2 | 4 | ||||||||
MIRT494743 | ARHGAP1 | Rho GTPase activating protein 1 | 2 | 6 | ||||||||
MIRT496491 | MAST3 | microtubule associated serine/threonine kinase 3 | 2 | 2 | ||||||||
MIRT503312 | FICD | FIC domain containing | 2 | 4 | ||||||||
MIRT503507 | ZNF623 | zinc finger protein 623 | 2 | 2 | ||||||||
MIRT504182 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT505010 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT505352 | TMEM167A | transmembrane protein 167A | 2 | 2 | ||||||||
MIRT505645 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT505710 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT505777 | SATB2 | SATB homeobox 2 | 2 | 6 | ||||||||
MIRT506208 | PHF19 | PHD finger protein 19 | 2 | 2 | ||||||||
MIRT506251 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT507786 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT508005 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT508857 | ZRSR1 | zinc finger CCCH-type, RNA binding motif and serine/arginine rich 1 | 2 | 4 | ||||||||
MIRT510546 | XBP1P1 | X-box binding protein 1 pseudogene 1 | 2 | 4 | ||||||||
MIRT511892 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT512907 | UBL4A | ubiquitin like 4A | 2 | 2 | ||||||||
MIRT513600 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT521241 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT521321 | RRAGD | Ras related GTP binding D | 2 | 4 | ||||||||
MIRT525281 | C18orf32 | chromosome 18 open reading frame 32 | 2 | 2 | ||||||||
MIRT528650 | RWDD2A | RWD domain containing 2A | 2 | 4 | ||||||||
MIRT535101 | PODXL | podocalyxin like | 2 | 2 | ||||||||
MIRT547752 | KBTBD6 | kelch repeat and BTB domain containing 6 | 2 | 4 | ||||||||
MIRT547865 | HSPA13 | heat shock protein family A (Hsp70) member 13 | 2 | 2 | ||||||||
MIRT549170 | BMP3 | bone morphogenetic protein 3 | 2 | 2 | ||||||||
MIRT550115 | SLC35G2 | solute carrier family 35 member G2 | 2 | 2 | ||||||||
MIRT556097 | MOAP1 | modulator of apoptosis 1 | 2 | 2 | ||||||||
MIRT557172 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT557422 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT557931 | FAM73A | mitoguardin 1 | 2 | 2 | ||||||||
MIRT568804 | VPS37D | VPS37D, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT571326 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT572598 | PAPLN | papilin, proteoglycan like sulfated glycoprotein | 2 | 2 | ||||||||
MIRT573437 | APOPT1 | apoptogenic 1, mitochondrial | 2 | 2 | ||||||||
MIRT574092 | VASN | vasorin | 2 | 2 | ||||||||
MIRT608688 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT608800 | ITGA11 | integrin subunit alpha 11 | 2 | 4 | ||||||||
MIRT610332 | SSX5 | SSX family member 5 | 2 | 2 | ||||||||
MIRT613158 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT625407 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | 2 | 2 | ||||||||
MIRT636603 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT638573 | IER5 | immediate early response 5 | 2 | 2 | ||||||||
MIRT639686 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT677979 | ITGB3 | integrin subunit beta 3 | 2 | 2 | ||||||||
MIRT685217 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT702570 | JARID2 | jumonji and AT-rich interaction domain containing 2 | 2 | 2 | ||||||||
MIRT706259 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT734675 | HMGB1 | high mobility group box 1 | 3 | 0 | ||||||||
MIRT736369 | HSPA1A | heat shock protein family A (Hsp70) member 1A | 1 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|